首页 | 本学科首页   官方微博 | 高级检索  
     

Visfatin与肥胖及糖尿病关系的研究进展
引用本文:杨洁瑾(综述),刘伟(审校). Visfatin与肥胖及糖尿病关系的研究进展[J]. 上海交通大学学报(医学版), 2008, 28(9)
作者姓名:杨洁瑾(综述)  刘伟(审校)
作者单位:上海交通大学医学院仁济医院内分泌科
摘    要:内脏脂肪素(Visfatin)是新近发现的一种脂肪细胞因子,以前被称为前B细胞集落增强因子(PBEF)。近来许多研究发现,Visfatin具有类似胰岛素的生物效应,并能促进脂肪细胞的分化、抑制肝糖原的释放和促血管平滑肌细胞成熟。Visfatin水平与糖、脂代谢相关。对于Visfatin的深入研究或许可使其成为糖尿病及代谢综合征治疗的一个新靶点。

关 键 词:Visfatin/前B细胞集落增强因子  脂肪细胞因子  肥胖  糖尿病  胰岛素抵抗

Research progress in relationship between Visfatin and obesity and diabetes mellitus
YANG Jie-jin,LIU Wei. Research progress in relationship between Visfatin and obesity and diabetes mellitus[J]. Journal of Shanghai Jiaotong University:Medical Science, 2008, 28(9)
Authors:YANG Jie-jin  LIU Wei
Abstract:Visfatin is a novel identified adipocytokine which was named as pre-B cell colony-enhancing factor(PEBF) before.Many studies have revealed its insulin-mimetic action.Visfatin can promote the differentiation of adipocytes,suppress the glucose release of hepatocytes,and accelerate the maturation of smooth muscle cells.Visfatin is related with the metabolism of glucose and lipid.Further studies on Visfatin may facilitate the treatment of diabetes mellitus and metabolic syndrome.
Keywords:Visfatin/pre-B cell colony-enhancing factor  adipocytokine  obesity  diabetes mellitus  insulin resistance
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号